Functional significance of sequence variation among miR-200/205 families of  miRNAs in ovarian cancer by Jabbari, Neda
 
FUNCTIONAL SIGNIFICANCE OF SEQUENCE VARIATION 


























In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy in the 











Copyright © Neda Jabbari 2015 
 
FUNCTIONAL SIGNIFICANCE OF SEQUENCE VARIATION 






















Approved by:   
   
Dr. John F. McDonald, Advisor 
School of Biology 
Georgia Institute of Technology 
 Dr. Yuhong Fan 
School of Biology 
Georgia Institute of Technology 
   
Dr. Alfred H.Merrill, Jr. 
School of Biology 
Georgia Institute of Technology 
 Dr. Susan N. Thomas 
School of Mechanical Engineering 
Georgia Institute of Technology 
   
Dr. Fredrik Vannberg 
School of Biology 
Georgia Institute of Technology 
  
   































 I wish to express my deepest gratitude to my advisor, Dr John McDonald for 
supervising my PhD research over the past few years. He has been a great mentor whose 
enthusiasm for science, continuous support, constructive feedbacks and advice have 
enabled this whole PhD and my path to becoming a scientist I am today. I would like to 
warmly thank my committee members, Dr Alfred Merrill, Dr Yuhong Fan, Dr Susan 
Thomas and Dr Fredrik Vannberg for their service on my committee and their insightful 
suggestions and feedbacks that improved the quality of this work. 
I wish to extend my warm thanks to all the McDonald lab members without 
whose help this work wouldn’t be possible: Dr L.DeEtte Walker for her continuous care 
and support and numerous acts of assistance; Dr Lilya Matyunina and Dr Christopher 
Hill for their constructive suggestions, feedbacks and contributions to my work; Dr 
Roman Mezencev, Dr Lijuan Wang, Dr Vinay Mittal and Dr Andrew Huang for their 
guidance and insightful comments whenever I needed; Mengnan Zhang for her sisterly 
support and help and Ashley Reavis for her eagerness to learn and contribution to my 
projects. In addition to the McDonald lab members, I am also grateful to have had caring 
friends from all over the world who have made this journey more exciting and rewarding. 
Finally, I would like to give my special thanks to my amazing parents, Parviz and 
Zhaleh, and my sisters, Nasim and Hedieh without whose love, support and 
encouragement I would not be here. They have genuinely helped me figure out many 
decisions and have given me every opportunity to pursue my dreams. I am honored and 
eternally thankful to have them in my life. 
 
 v 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES viii 
LIST OF FIGURES ix 
LIST OF ABBREVIATIONS xi 
SUMMARY xii 
CHAPTER 
1 INTRODUCTION 1 
Background 1 
Regulation of EMT by miRNAs 2 
2 SEQUENCE VARIATION AMONG MEMBERS OF THE MIR-200 
MICRORNA FAMILY IS CORRELATED WITH VARIATION IN THE 
ABILITY TO INDUCE HALLMARKS OF MESENCHYMAL-EPITHELIAL 
TRANSITION IN OVARIAN CANCER CELLS 6 
Preliminary comments 6 
Abstract 6 
      Background 6 
      Methods 7 
      Results 7 
      Conclusions 7 
Background 7 
Results 9 
      MiR-429 is capable of inducing Mesenchymal-Epithelial Transition in 
multiple mesenchymal-like ovarian cancer cell lines 9 
 
 vi 
      All members of the miR-200 miRNA family are capable of inducing 
Mesenchymal-Epithelial Transition in ovarian cancer mesenchymal-like 
cells 10 
      HEY cells transfected by miR-200 family members display significant 
variation in sensitivity to cisplatin associated with variation within the 




      Cell culture and miRNA transfection 20 
      Image capture and morphological assessment 21 
      Quantitative reverse transcription real-time PCR (qRT-PCR) 21 
      Immunostaining 22 
      Cisplatin sensitivity 23 
      Statistical analysis 23 
3 FUNCTIONAL AND EVOLUTIONARY SIGNIFICANCE OF HUMAN 
MICRORNA SEED REGION MUTATIONS 24 
Preliminary comments 24 
Abstract 24 
Introduction 25 
Results and Discussion 26 
Materials and Methods 37 
      Computational predictions of miRNA target and overlap 37 
      Cell culture and transfections 38 
      RNA isolation and whole genome microarray 39 
      Microarray data analysis 39 
      Orthologous genes 40 
 
 vii 
4 EVIDENCE FOR FUNCTIONALLY SIGNIFICANT INTERACTIONS 
BETWEEN SEED REGION AND NON-SEED REGION AMONG MEMBERS 
OF THE MIR-200 FAMILY OF MICRORNAS 41 





Material and Methods 51 
      Cell culture and miRNA transfection 51 
      Quantitative reverse transcription real-time PCR (qRT-PCR) 52 
      RNA isolation and whole genome microarray 52 
      Microarray data analysis 53 
      Cisplatin sensitivity 53 
5 CONCLUSIONS 55 
APPENDIX A: SUPPLEMENTARY DATA FOR CHAPTER 3 59 





LIST OF TABLES 
Page 
Table 2.1: Prediction of miR-200 family binding sites on FN1, ZEB1, ZEB2, KRT7, 
KRT8 and KRT18 mRNAs. 16 
Table 4.1: Representative genes associated with cisplatin resistance that are down 
regulated in miR-200b transfection and not changed in miR-429 transfection47 
Table A.1: Target overlap for miRNAs with identical seeds.  59 
Table A.2: Target overlap for miRNAs with non-identical seeds. 59 
Table A.3: Fold-change for all (5229) significantly differentially expressed genes after 
ectopic expression of miR-429 in HEY cells. 59 
Table A.4: Fold-change for all (10456) significantly differentially expressed genes after 
ectopic expression of M12 in HEY cells. 59 
Table A.5: Fold-change for all (11277) significantly differentially expressed genes after 
ectopic expression of M14 in HEY cells. 59 
Table A.6: Fold-change for all (10475) significantly differentially expressed genes after 
ectopic expression of M5 in HEY cells. 59 





LIST OF FIGURES 
Page 
Figure 2.1: Overexpression of miR-429 in SKOV-3 and HEY A8 cells induces 
morphological and molecular changes consistent with the induction of 
Mesenchymal Epithelial Transition. 10 
Figure 2.2: Overexpression of the miR-200 family induces morphological changes 
consistent with the induction of MET. 11 
Figure 2.3: Overexpression of the miR-200 family induces changes in biomarkers 
consistent with the induction of MET. 13 
Figure 2.4: Immunostaining of cells for CDH1 (A) and FN1 (B) proteins. 14 
Figure 2.5: Effect of overexpression of members of miR-200 family in HEY cells on 
cisplatin sensitivity. 18 
Figure 3.1: A single nucleotide difference in seed region of miRNAs is associated with a 
major change in regulated target genes. 28 
Figure 3.2: Sequence alignments of miR-429, miR-200b, miR-141, miR-205, M12, M14 
and M5. 30 
Figure 3.3: Overlap among differentially expressed genes in HEY cells after ectopic 
expression of miRNAs with different seed region sequences. 32 
Figure 3.4: The high functional cost of even single nucleotide changes in miRNA seed 
regions implies a mechanism of miRNA regulatory evolution. 34 
Figure 3.5: Mouse and human miRNAs share sequentially identical seed regions but 
regulate highly divergent groups of target genes. 36 
Figure 4.1: Effect of over expression M4b in HEY cells on cisplatin sensitivity 44 
Figure 4.2: Overlap among differentially expressed genes in HEY cells transfected with 
miRNAs with different non seed regions 46 
Figure 4.3: Expression levels of representative cisplatin resistance genes in miRNA 
transfected cells are predictive of the cells’ response to cisplatin 50 
Figure A.1: One nucleotide difference or 7 nucleotide differences in the seed regions of 
miRNAs is predicted to be associated with equivalent levels of change in 
regulated target genes. 60 
 
 x 
Figure A.2: Distribution of percent overlap of miRanda-mirSVR predicted targets of 










LIST OF ABBREVIATIONS 
 
EMT  Epithelial-Mesenchymal Transition 
MET  Mesenchymal-Epithelial Transition 
miRNA     MicroRNA 
OC                                                                                    Ovarian Cancer  
TYMS                                                                                              Thymidylate Synthetase 
ANXA4                                                                                                              Annexin A4 
Cul4A                                                                                                                      Cullin4A 
FOXO1                                                                                                      Forkhead Box O1 
Rac1                                                               Ras-Related C3 Botulinum Toxin Substrate 1 











MicroRNAs are small RNAs that regulate large suites of target genes. Recent 
findings have implicated members of the miR-200 family of miRNAs in the epithelial-
mesenchymal/mesenchymal-epithelial (EMT/MET) process that is associated with cancer 
metastasis. In chapter 2, our results indicate that significant variation exists among miR-
200 miRNAs in the regulation of molecular processes underlying specific features of the 
EMT/MET process and that this variation is associated with sequence variation mapping 
to both the seed and non-seed region of individual family members. Our results generally 
support the notion that modulations in the expression of miRNAs involved in EMT may 
serve as the basis of new strategies in the treatment of cancer. In chapter 3, we present a 
set of analyses on the functional and evolutionary significance of human miRNA seed 
region variations. We provide computational and experimental evidence that as little as a 
single nucleotide change within seed regions dramatically alters the spectrum of mRNAs 
directly or indirectly regulated by the over expressed miRNA and that additional seed 
nucleotide substitutions have no significant added effect. Our results help explain the 
highly conserved nature of seed regions among many miRNA families within and across 
species and develop a better understanding of the evolution of miRNA mediated 
regulation. In chapter 4, we provide evidence for seed/non-seed region interactions in the 







Cancer is a major burden of disease worldwide. Chances of survival are greater if 
cancer is diagnosed when still confined to the organ of origin, however, survival rates 
decline as tumors spread and metastasize to distant organs. During metastasis, cells 
initially acquire properties that allow at least partial separation from the original mass to 
escape through boundary matrices and intravasate into a conduit vessles (Wells, Chao et 
al. 2011) . At the metastatic site, the cells exit the blood or lymphatic vessels, form 
micrometastatic nodules, adapt and reprogram the surrounding stroma, and eventually 
form macrometastases (Yao, Dai et al. 2011). Both differentiated primary tumors and 
metastases often have a similar heterogeneous organization that is characterized by 
regions of dedifferentiation, particularly at the invasive front. This de-differentiation is a 
hallmark of an Epithelial–Mesenchymal Transition (EMT)(Brabletz 2012). Once 
epithelial cells that display a highly baso-apical polarization (Voulgari and Pintzas 2009) 
become competent to respond to EMT-inducing signals, the signals can promote loss of 
this polarity, disruption of the intercellular adhesion complexes (Moreno-Bueno, Portillo 
et al. 2008) and a complete reorganization of the actin cytoskeleton (Yilmaz and 
Christofori 2009). Simultaneously, the cells acquire migratory and invasive properties 
that allow them to migrate through the extracellular matrix and disseminate from the 
primary tumor (Acloque, Adams et al. 2009, Brabletz 2012). The disseminated cells 
recruited to the target  organs may re-acquire epithelial characteristics similar to the 
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primary tumor and undergo a reverse phenotypic transition from mesenchymal to 
epithelial by a process called Mesenchymal- Epithelial Transition (MET) (Thiery and 
Sleeman 2006). This latter change may be triggered by the local environment after 
extravasation towards the parenchyma of the invaded organs (Foroni, Broggini et al. 
2012). 
The EMT regulatory networks are closely connected, and modulation of any of 
these networks has a profound effect on every other network (Craene and Berx 2013). 
The most extensively studied network is built around EMT inducing transcription factors 
that repress E-cadherin, a major component of adherens junctions and hallmark of the 
epithelial integrity (Peinado, Olmeda et al. 2007), and also simultaneously repress several 
other junctional proteins, which facilitate EMT (Ikenouchi, Matsuda et al. 2003, 
Vandewalle, Comijn et al. 2005). Besides the well-established transcriptional 
reprogramming during EMT, post-transcriptional mechanisms such as small non-coding 
RNAs known as miRNAs provide an additional layer of gene regulation (Craene and 
Berx 2013, Lamouille, Subramanyam et al. 2013). In the next sections, we summarize our 
findings on the effectiveness of a panel of miRNAs on the induction of hallmarks of 
MET in ovarian cancer cells, functional and evolutionary significance of sequence 
variation among miRNAs and provide evidence for the functionally significant 
interactions between seed and non-seed regions among members of the miR-200 family. 
                      Regulation of EMT by miRNAs 
MiRNAs are endogenous non-coding RNAs (~22 nt) that regulate gene 
expression at the post-transcriptional level (Bartel 2004). MiRNA target recognition is 
primarily determined by pairing of the highly conserved miRNA seed sequence 
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(nucleotides2–8) to complementary sites in target mRNAs (Lewis, Shih et al. 2003, 
Friedman, Farh et al. 2009). Many miRNAs have been directly or indirectly associated 
with EMT (Zhang and Ma 2012). The miR-200 family (miR-200a, miR-200b, miR-429, 
miR-200c and miR-141) is a widely known miRNA family that is strongly associated 
with epithelial differentiation regulating both EMT and MET (Gregory, Bert et al. 2008, 
Park, Gaur et al. 2008).  
In chapter 2, we demonstrate the effectiveness of the members of the miR-200 
family to induce MET in ovarian cancer cells. It has been previously shown that a well 
characterized mesenchymal-like OC cell line (HEY) undergoes MET in response to 
ectopic over-expression of miR-429 (Chen, Wang et al. 2011). In the study presented in 
chapter 2, we first determined that the ability of miR-429 to induce MET extends to other 
mesenchymal-like OC cell lines, HEY A8 (Mills, May et al. 1990) and SKOV-3 (Fogh, 
Fogh et al. 1977, Lis, Touboul et al. 2014). We next verified that ectopic over expression 
of each member of the miR-200 family induces significant changes in many of the 
morphological and molecular hallmarks that are associated with MET in HEY OC cell 
lines. More importantly, we found that significant differences exist among these members 
in the expression of a panel of epithelial and mesenchymal biomarkers and in induced 
cisplatin sensitivity. Interestingly, this functional variability was associated with variation 
mapping to the seed and non-seed regions of individual miRNAs.  
In chapter 3, we present a set of computational and experimental analyses on the 
functional and evolutionary significance of human miRNA seed region mutations. 
Initially, the relationship between seed sequence variation and miRNA target overlap 
across all conserved miRNAs was assessed using miRNA target prediction tools. The 
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analyses indicated that as few as one nucleotide change within the 7-mer miRNA seed 
region (nucleotides 2–8 at the 5′-end of the miRNA) dramatically alters the spectrum of 
targeted mRNAs. Additionally, computational analyses predicted that additional seed 
nucleotide substitutions have little to no additional effect on miRNA targeting. We next 
present experiments that evaluate the computationally driven results and test the 
consequence of seed region variations on patterns of gene expression. In order to do so, 
we conducted ectopic over expression of synthetic miRNAs with variable seed regions 
but with identical non-seed regions. Consistent with our computationally assessed results, 
the experimental data again demonstrate that as few as one nucleotide change within seed 
regions dramatically alters the spectrum of mRNAs directly or indirectly regulated by the 
over expressed miRNA and additional seed nucleotide substitutions (5 nt) have no 
significant additional effect. Our results help explain the highly conserved nature of seed 
regions among many miRNA families within and across species and develop a better 
understanding of the evolution of miRNA mediated regulation. 
In chapter 2, we have demonstrated that over-expression of miR-200b in 
mesenchymal-like ovarian cancer cells significantly increases sensitivity to the 
chemotherapeutic drug cisplatin and that this functionally significant change is associated 
with sequence variation in the non-seed region on miR-200b. In chapter 4, we report that 
the miR-200b induced increase in drug sensitivity is correlated with significant gene 
expression changes including the down-regulation of genes known to be associated with 
cisplatin resistance in cancer cells. We further demonstrate evidence that upon change of 
a single nucleotide within the miR-200b seed region, its ability to impart cisplatin 
sensitivity is lost. Our results provide an example on the significance of seed /non-seed 
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SEQUENCE VARIATION AMONG MEMBERS OF THE MIR-200 
MICRORNA FAMILY IS CORRELATED WITH VARIATION IN 
THE ABILITY TO INDUCE HALLMARKS OF MESENCHYMAL-
EPITHELIAL TRANSITION IN OVARIAN CANCER CELLS 
  
Preliminary comments 
The contents in this chapter are published in the Journal of Ovarian Research 
under the title “Sequence variation among members of the miR-200 microRNA family is 
correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial 
transition in ovarian cancer cells”. I am first author on this paper and I have performed all 
the experiments and data analyses in the study. Ashley Reavis has assisted with the 
experiments on HEY A8 and SKOV-3 cells.  
Abstract 
Background 
 Epithelial-Mesenchymal Transition (EMT) is a transient and reversible (MET) 
process by which epithelial cells acquire mesenchymal, fibroblast-like cell characteristics 
including reduced intercellular adhesion and increased cell motility. While EMT/MET 
has long been recognized as an essential component of early embryonic development, 
there is a growing body of evidence indicating that EMT/MET also plays a key role in 
ovarian cancer metastasis. Recent findings have implicated members of the miR-200 





 Individual members of the miR-200 family of miRNAs were transiently 
overexpressed in metastatic (mesenchymal-like) OC cell lines. Changes in morphology, 
molecular profiles and drug sensitivity were monitored relative to cells transfected with a 
negative control miRNA.  
Results 
 Morphological hallmarks of MET were detected in cells transfected with all 
members of the miR-200 family. Gene expression profiling demonstrated up regulation 
of epithelial biomarkers and down regulation of mesenchymal biomarkers in transfected 
cells although significant variation in molecular response and drug sensitivity was 
associated with different miR-200 family members.  
Conclusions 
 Our results indicate that although ectopic overexpression of all members of the 
miR-200 family in mesenchymal-like OC cells results in morphological changes 
characteristic of MET, the underlying molecular changes and induced drug sensitivities 
are highly variable and correlated with sequence variation within the seed and non-seed 
regions of individual miR-200 family members. 
Background 
 Ovarian cancer is the most lethal of all gynecologic malignancies (Siegel, Ward et 
al. 2011). The majority of ovarian cancer related deaths is attributable to the spread of 
cancer cells from the primary tumor to metastatic sites throughout the abdominal cavity 
(Halkia, Spiliotis et al. 2012). During early stages of metastasis, a subset of primary 
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epithelial tumor cells undergo Epithelial-Mesenchymal Transition, whereby cell-cell 
adhesion complexes are disrupted, the characteristic apico-basal polarity of the cells is 
lost and cells acquire elevated levels of motility, invasiveness and resistance to standard 
chemotherapeutic agents (Huber, Kraut et al. 2005, Acloque, Adams et al. 2009, Brabletz 
2012). Following attachment to secondary sites, metastasizing cells undergo a 
complementary Mesenchymal-Epithelial Transition whereby the metastatic cells 
reacquire epithelial morphology and other features characteristic of the primary tumor 
cells (Chaffer, Thompson et al. 2007). Because of the high clinical significance of 
metastasis, considerable effort is currently being directed towards the development of 
new classes of agents that may reduce the spread of cancer cells by inducing MET 
(Monteiro and Fodde 2010).  
 We have previously shown that mesenchymal-like ovarian cancer cells undergo 
MET in response to ectopic overexpression of miR-429, a member of the miR-200 family 
of miRNAs (Chen, Wang et al. 2011). This finding is consistent with earlier observations 
implicating members of the miR-200 miRNA family in MET (Gregory, Bert et al. 2008, 
Park, Gaur et al. 2008). Here, we report the results of a systematic examination of the 
effects of ectopic overexpression of members of the miR-200 family in ovarian cancer 
mesenchymal-like cell lines. The results indicate that although overexpression of each 
member of the miR-200 family induces significant changes in many of the morphological 
and molecular hallmarks of MET, significant differences exist among family members in 
the expression of EMT/MET biomarkers and in induced drug sensitivity. This functional 
variability is associated with sequence variation mapping to both the seed and non-seed 




MiR-429 is capable of inducing Mesenchymal-Epithelial Transition in multiple 
mesenchymal-like ovarian cancer cell lines 
 We have previously shown that ectopically overexpressed miR-429 induces MET 
in a well-characterized mesenchymal-like OC cell line (HEY) (Chen, Wang et al. 2011). 
We were interested in determining if this ability of miR-429 to induce MET extends to 
other mesenchymal-like ovarian cancer cell lines as well. Consistent with our previous 
results, ectopically overexpressed miR-429 in two additional mesenchymal-like OC cell 
lines (HEY A8 (Mills, May et al. 1990) and SKOV-3 (Fogh, Fogh et al. 1977, Lis, 
Touboul et al. 2014)) induced morphological and molecular changes consistent with 
MET (Figure  2.1). MiR-429 transfected SKOV-3 and HEY A8 cells displayed a change 
from the elongated and fibroblast like shape characteristic of mesenchymal cells to the 
more rounded shape characteristic of epithelial cells. This morphological change was 
objectively validated using the CellProfiler cell image analysis software (Carpenter, 
Jones et al. 2006). Changes in expression of two epithelial KRT8 and KRT18 and two 
mesenchymal [ZEB1 and ZEB2 (zinc finger E-box binding homeobox 1 and 2)] 





Figure 2.1. Overexpression of miR-429 in SKOV-3 and HEY A8 cells induces 
morphological and molecular changes consistent with the induction of Mesenchymal 
Epithelial Transition. (A) Representative phase contrast microscopy images of HEY A8 
cells transfected with (i) nc-miR and (ii) miR-429, and SKOV-3 cells transfected with 
(iii) nc-miR and (iv) miR-429, 48 hours post transfection. Scale bars indicate 50 μm. (B) 
The accumulation of rounded epithelial-like cells occurred in miR-429 transfected groups 
(eccentricity: a score of 0 = circular shape, a score of 1 = linear shape). Values represent 
mean ± SEM. Mann-Whitney U test was used to detect significance of differences 
between miR-429 and negative control groups (*P <0.05, **P <0.005, n = 127-258 cells 
analyzed per group). (C) Relative mRNA expression of representative epithelial and 
mesenchymal biomarkers. Expression values in miR-429 transfection are normalized to 
negative control in each cell line and represent mean ± SEM of three biological replicates 
each performed in three technical replicates. Student’s t-test was used to detect 
significance of differences between miR-429 and negative control group in each cell line 
(*P <0.005, **P < 0.0005,). 
 
 
All members of the miR-200 miRNA family are capable of inducing Mesenchymal-
Epithelial Transition in ovarian cancer mesenchymal-like cells 
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 All members of the miR-200 family have previously been either directly or 
indirectly implicated in EMT (Gregory, Bert et al. 2008, Park, Gaur et al. 2008). Having 
established that ectopic over expression of miR-429, a member of the miR-200 miRNA 
family (Figure 2.2A), induces MET in a variety of mesenchymal-like OC cell lines, we 
were interested in determining if this MET-inducing potential extends to other members 
of the miR-200 family as well.  
 
 
Figure 2.2. Overexpression of the miR-200 family induces morphological changes 
consistent with the induction of MET. (A) Multiple sequence alignment of the miR-200 
family. Alignment is performed using the ClustalW2 program. Sequence differences 
relative to miR-429 are highlighted. (B) Representative phase contrast microscopy 
images of (i) HEY cells (not transfected), HEY cells transfected with (ii) nc-miR, (iii) 
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miR-200a, (iv)miR-141, (v) miR-200b, (vi) miR-200c, and (vii) miR-429, 48 hours post 
transfection. Scale bars represent 50 μm. (C) The accumulation of rounded epithelial-like 
cells occurred in miR-200 family transfected cells. Values represent mean ± SEM 
(n = 124-211 cells analyzed per group). Mann-Whitney U test is used to detect significant 
differences from the negative control (*P <0.0001, NS = not significant).  
 
 
The results in Figure 2.2 demonstrate that overexpression of all miR-200 family members 
results in a significant change from the elongated, spindle-shaped morphology of the 
mesenchymal-like cells to the more rounded, cuboidal morphology characteristic of 
epithelial cells. No detectable change in morphology was observed in cells treated with 
the negative control (nc-miR).  
 The expression levels of a series of previously established epithelial and 
mesenchymal biomarkers (Zeisberg and Neilson 2009) were monitored in HEY cells 
transfected with members of the miR-200 family. Consistent with acquisition of a more 
epithelial phenotype, expression levels of all of the epithelial biomarkers (KRT8, KRT18, 
KRT7) were increased after overexpression of each member of the miR-200 family 
(Figure  2.3). As expected, the mesenchymal biomarkers ZEB1/ZEB2 displayed a general 
reduction in expression levels after overexpression of each member of the miR-200 
family. The mesenchymal biomarker FN1 was also significantly down regulated in cells 




Figure 2.3. Overexpression of the miR-200 family induces changes in biomarkers 
consistent with the induction of MET.  Expression values of representative epithelial 
and mesenchymal biomarkers after overexpression of miR-200 family members in HEY 
cells are normalized to negative control (nc-miR) and represent mean ± SEM of at least 
three biological replicates each performed in three technical replicates. Student’s t-test is 
used to detect significant differences from the nc-miR transfection (*P <0.05, **P 
<0.005, ***P <0.0005).  
  
 
 Human miRNAs are known to be capable of regulating expression of their target 
genes by modulating mRNA levels and/or blocking translation (Bartel 2004). Thus, to 
further explore the inconsistent response of changes in FN1 RNA levels after transfection 
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by individual members of miR200 family, we additionally monitored expression changes 
on the protein level by immunofluorescence staining. The epithelial biomarker, CDH1 
(Takeichi 1990, Zeisberg and Neilson 2009), was included in these assays as an 
additional control (Figure 2.4). 
 
Figure 2.4. Immunostaining of cells for CDH1 (A) and FN1 (B) proteins. (i) HEY 
cells (not transfected), HEY cells transfected with (ii) nc-miR, (iii) miR-200a, (iv)miR-
141, (v) miR-200b, (vi) miR-200c, and (vii) miR-429. DAPI was used to stain the cell 






 Consistent with the observed increase in expression levels of each of the epithelial 
biomarkers monitored on the RNA level, CDH1 protein was detected in all transfected 
cells but was absent in un-transfected cells and in cells transfected with the negative 
control. Interestingly, levels of FN1 protein were generally consistent with what was 
observed on the RNA level, i.e., protein levels were significantly down regulated in cells 
transfected by miR-200b, miR-200c or miR-429 but unchanged or slightly up-regulated 
in cells transfected by miR-200a, miR-141 (Figure 2.4). Collectively, these findings 
suggest that FN1 is a regulatory target of miR-200b, miR-200c and miR-429 but is not 
subject to regulation by miR-200a and miR-141. In addition, since a change from a 
mesenchymal to an epithelial phenotype was observed in cells transfected by all members 
of the miR-200 family, we conclude that FN1 is non-essential for MET in OC. 
 Previous studies indicate that the most functionally significant component of 
miRNA/mRNA pairing involves the miRNA “seed region”, i.e., nucleotides 2-8 on the 5′ 
end of the miRNA (Lewis, Shih et al. 2003). Although all members of the miR-200 
family are sequentially distinct, miR-200b, miR-200c and miR-429 are sequentially 
identical within their respective seed regions (Figure 2.2A). This identity may explain 
their shared ability to down regulate FN1 when ectopically over expressed in HEY cells. 
To further explore this possibility, we utilized three miRNA target prediction algorithms 
(miRanda (Betel, Wilson et al. 2008), miRDB (Wang 2008), and TargetScan (Lewis, 
Burge et al. 2005)) to identify members of the miR-200 family that are predicted to 
directly target FN1 mRNA and the other biomarkers monitored in our PCR experiments. 
The results, presented in Table  2.1, indicate that all three algorithms predict the presence 
of binding sites in FN1 mRNA for miR-200b, miR-200c and miR-429, but not for miR-
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200a, miR-141. These computational predictions are consistent with our experimental 
results and indicate that differences in target specificity for FN1 mRNA between the 
miR-200 family members accounts for the observed variation in regulation of FN1 
expression. 
 
Table 2.1. Prediction of miR-200 family binding sites on FN1, ZEB1, ZEB2, KRT7, 
KRT8 and KRT18 mRNAs. Only those genes predicted to be targeted by miR-200 
family members were observed to be down regulated in cells in which they were 
ectopically overexpressed. A: miRanda (mirSVR ≤ -0.2), B: miRDB, C: TargetScan 













HEY cells transfected by miR-200 family members display significant variation in 
sensitivity to cisplatin associated with variation within the non-seed region of 
individual miRNAs 
 Previous studies indicate that EMT is often associated with decreased sensitivity 
of a variety of cancer cells to chemotherapy (Shah, Summy et al. 2007, Adam, Zhong et 
al. 2009, Arumugam, Ramachandran et al. 2009). Consistent with this observation, 
ovarian cancer cells undergoing EMT have been reported to display a decreased 
sensitivity to platinum-based drugs, a frequently employed first line therapeutic in the 
treatment of ovarian cancer (Haslehurst, Koti et al. 2012, Marchini, Fruscio et al. 2013). 
Since EMT is reported to decrease the sensitivity of OC epithelial cells to platinum-based 
 miR-200b miR-200c miR-429 miR-200a miR-141 
 A B C A B C A B C A B C A B C 
FN1 2 2 1 2 2 1 2 2 1 0 0 0 0 0 0 
ZEB1 5 6 5 5 6 5 5 6 5 3 3 3 3 3 3 
ZEB2 6 5 6 6 5 6 6 5 6 3 4 2 3 4 2 
KRT7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
KRT8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
KRT18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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drugs, we were interested in determining if miR-induced MET of mesenchymal-like OC 
cells would induce an opposite effect, i.e., be associated with an increased sensitivity of 
OC cells to platinum-based drugs. To explore this possibility, we monitored the drug 
susceptibility (IC50) of HEY cells to cisplatin after miRNA-induced MET relative to 
controls. 
 The results presented in Figure 2.5 demonstrate that ectopic over expression of all 
members of the miR-200 family results in a significant increase in cisplatin sensitivity 
relative to negative control. While notable variation was observed among cells 
transfected by different members of the miR-200 family, in most cases this variation was 
not statistically significant. Cells transfected with miR-200b were significantly more 
sensitive to cisplatin than those transfected with miR-429 (p < 0.05). Interestingly, these 
two miRNAs share identical seed regions suggesting that non-seed sequences may be of 




Figure 2.5. Effect of overexpression of members of miR-200 family in HEY cells on 
cisplatin sensitivity. (A) IC50 values are presented as mean ± SEM of at least 3 
independent experiments with 3 replicated wells per drug concentration. Statistical 
analysis is performed using ANOVA and Tukey’s multiple comparison test as a post-hoc 
test and significant differences from the negative control (nc-miR) group are presented, 
*P ≤0.05, **P ≤0.005. (B) Qualitative evaluation of cell viability in presence of (i) 20 μM 
and (ii) 0 μM cisplatin in HEY cells alone or transfected with different members of miR-
200 family or nc-miR (crystal violet staining). Scale bars represent 100 μm. 
 
                                                                 
 
Discussion 
 It is widely acknowledged that the metastatic spread of cancer cells is responsible 
for most cancer related deaths (Mehlen and Puisieux 2006, Bacac and Stamenkovic 
2008). This is particularly true for ovarian cancer where the prospect of favorable 
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outcome drops precipitously once cancer cells migrate beyond the confines of the 
primary tumor (Howlader N). Since the EMT/MET process is believed to play a central 
role in the metastasis of many cancers (Thiery 2002) including OC (Vergara, Merlot et al. 
2010, Lili, Matyunina et al. 2013), considerable effort is being focused on the discovery 
and development of reagents that may intervene in this process for therapeutic benefit 
(Monteiro and Fodde 2010).  
 We previously demonstrated that ectopic over expression of miR-429, a member 
of the miR-200 family of microRNAs, is sufficient to convert highly metastatic OC 
mesenchymal-like cells to epithelial phenotype with a concomitant reduction in invasive 
and migratory potentials (Chen, Wang et al. 2011). Prompted by these initial results, we 
were interested in determining if the MET-inducing properties of miR-429 extended to 
other OC mesenchymal-like cell lines and if other members of the miR-200 family were 
also capable of exerting these potentially anti-metastatic effects. Finally, since previous 
studies have shown that ovarian cancer cells induced to undergo EMT display a 
significantly decreased sensitivity to platinum-based drugs (Haslehurst, Koti et al. 2012, 
Marchini, Fruscio et al. 2013), we were interested to determine if miRNA-induced 
reversal of the process (i.e., MET) might increase sensitivity to these drugs thereby 
demonstrating an additional potential therapeutic benefit of these small regulatory RNAs.  
 Consistent with our earlier studies, we found that ectopic overexpression of miR-
429 in two additional OC mesenchymal-like cell lines (SKOV-3 and HEY A8) results in 
morphological and molecular changes characteristic of MET. Ectopic over expression of 
other members of the miR-200 family in mesenchymal-like HEY cells also induced 
morphological changes characteristic of MET but underlying molecular changes were 
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found to be variable and attributable to sequence variation within the seed region of 
individual family elements. Finally, we tested the sensitivity of HEY cells to cisplatin 
after transfection with members of the miR-200 families relative to negative controls. 
The results demonstrate that although miR-200 family induced MET is generally 
correlated with a significant increase in sensitivity to cisplatin, significant variation exists 
among individual family members. In this case, the variability was associated with 
sequence variation mapping to the non-seed region of individual family members. 
Conclusions 
 Collectively our results are consistent with earlier findings from our lab (Chen, 
Wang et al. 2011) and others (Gregory, Bert et al. 2008, Park, Gaur et al. 2008) indicating 
that members of the miR-200 family are involved in EMT/MET and ovarian cancer 
metastasis. Our results also indicate that significant variation exists among family 
members in the regulation of molecular processes underlying specific features of the 
EMT/MET process and that this variation is associated with sequence variation mapping 
to both the seed and non-seed region of individual family members. Our results generally 
support the notion that exogenous modulations in the expression of miRNAs involved in 
EMT may serve as the basis of important new strategies in the treatment of ovarian and 
other types of cancer (Xia and Hui 2012). 
Methods 
Cell culture and miRNA transfection 
 HEY and HEY A8 ovarian cancer cell lines were provided by Gordon B. Mills 
(MD Anderson Cancer Center, Houston, TX). SKOV-3 ovarian cancer cells were 
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obtained from the American Type Culture Collection (ATCC, Manassas, VA). Cells were 
cultured in RPMI 1640 (Mediatech, Manassas, VA) supplemented with 10% FBS (Fetal 
Bovine Serum; Atlanta Biologicals, Lawrenceville, GA) and 1% antibiotic-antimycotic 
solution (Mediatech-Cellgro, Manassas, VA). For miRNA transfections, 6 × 104 cells 
were seeded per well in 24-well plates. Cells at exponential phase of growth were 
transfected with 30 nM miRNA purchased as Pre-miR miRNA Precursors (Ambion, 
Austin, TX) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and according to the 
manufacturer’s instructions. Cells were allowed to grow for 48 hours before RNA 
isolation. Ambion Pre-miR miRNA Precursor Negative Control was used as a negative 
control (nc-miR).  
Image capture and morphological assessment 
 Morphological changes were monitored using an Olympus IX51 microscope 
(Olympus Optical, Melville, NY). The effect of treatment on cell morphology was 
objectively measured using CellProfiler cell-imaging software (2.1.0) (Carpenter, Jones 
et al. 2006).  
Quantitative reverse transcription real-time PCR (qRT-PCR) 
 Total RNA was extracted from cells using the RNeasy mini kit (Qiagen, Valencia, 
CA). RNA concentrations were measured using a NanoDrop 1000 Spectrophotometer 
V3.2 (NanoDrop, Wilmington, DE). Highly pure RNA samples (A260/A280 between 2.0 
and 2.1) were converted into first-strand cDNA with the Superscript III First-strand 
Synthesis System (Invitrogen, Carlsbad, CA). Real-time PCR analyses were performed 
using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) on the CFX96 real-time PCR 
system (Bio-Rad, Hercules, CA).  
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 The primer sequences employed are as follows: KRT7 (keratin 7): forward 5′- 
GGACATCGAGATCGCCACCT-3′ and reverse 5′- ACCGCCACTGCTACTGCCA-3′; 
KRT8 (keratin 8): forward 5′- CCGTGGTTGTGAAGAAGATCG-3′ and reverse 5′-
GCTGTTCACTTGGGCAGGAC-3′; KRT18 (keratin 18): forward 5′-
TGAGACGTACAGTCCAGTCCTT-3′ and reverse 5′-
GCTCCATCTGTAGGGCGTAG-3′; GAPDH: forward 5′- 
TGCACCACCAACTGCTTAGC -3′ and reverse 5′- GGCATGGACTGTGGTCATGA -
3′. The primer sequences for mesenchymal biomarker genes were described previously 
(Chen, Wang et al. 2011). The threshold cycle and ΔΔCt method was used for calculating 
the relative amount of the target RNA. Expression values were normalized using GAPDH 
as a reference gene. 
Immunostaining 
 5 × 103 cells were cultured on eight well chamber slides. Cells at exponential 
phase of growth were transfected as indicated above. 48 hours after transfection, media 
was removed and cells were fixed in 10% neutral buffered formalin for 15 min. Cells 
were then washed, permeabilized with 0.5% Triton X-100 for 5 min, washed again and 
blocked with 5% BSA (Bovine Serum Albumin) in PBS for 1 hour. The slides were 
incubated with mouse monoclonal primary antibodies against CDH1 (E-cadherin) and 
FN1 (Fibronectin, 1:200; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in 5% BSA 
for 1 hour at room temperature. After washing, the slides were then incubated with Alexa 
Fluor 488 Rabbit Anti-Mouse secondary antibody (1:500, Molecular Probes, Inc., 
Eugene, OR) for 1 hour at room temperature. After a wash with PBS, counterstaining was 
performed using DAPI (4′,6-diamidino-2-phenylindole, 1:2000) in PBS for 30 min. Cells 
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were then mounted and expression status of protein biomarkers was assessed using the 
Zeiss confocal microscope system (Carl Zeiss, Jena, Germany).  
Cisplatin sensitivity 
 Aliquots of cells were seeded in 96-well plates and treated with nine 
concentrations of cisplatin ranging from 0.1-50 μM. After 72 hours, TOX-8 reagent 
(Resazurin based in vitro toxicology assay kit, Sigma-Aldrich, St Louis, MO) was added 
to the wells and fluorescence was measured (λex = 560 nm, λem = 590 nm). Outlier 
values were removed using Grubbs’ test. The ratio of the background-subtracted 
fluorescence intensities of drug treated to untreated cultures was calculated in 
percentages across all concentrations. IC50 values were determined by non-linear 
regression of log-transformed data using a normalized response-variable slope model 
with GraphPad Prism v.6 (GraphPad Software Inc., La Jolla, CA). 
Statistical analysis 
 Statistical significance of differences in qRT-PCR experiments between 
experimental and control samples was determined using a two-tailed Student’s t-test. 
Significance of differences in eccentricity profiles of experimental and control samples 
was evaluated using Mann-Whitney U test. Statistical significance of differences in mean 
IC50 values among miRNA transfections was tested using analysis of variance 
(ANOVA) and Tukey’s multiple comparison test as a post-hoc test. All experiments were 







FUNCTIONAL AND EVOLUTIONARY SIGNIFICANCE OF 
HUMAN MICRORNA SEED REGION MUTATIONS 
 
Preliminary comments 
 The contents of this chapter are published in PLoS ONE under the title 
“Functional and Evolutionary Significance of Human MicroRNA Seed Region 
Mutations” with me listed as a first coauthor. Dr. Chris Hill and I are co-first authors on 
this paper. Dr. Hill carried out all of the computational analyses on the relationship 
between miRNA seed variation and predicted target overlaps. I designed and conducted 
all of the wet lab experiments including cell culturing, transfection, RNA extractions. I 
collaborated with Dr. Lilya Matyunina in carrying out the microarray experiments and 
with Chris Hill on analysis of the microarray data.  
Abstract 
 MicroRNAs have emerged in recent years as important regulators of cell function 
in both normal and diseased cells. MiRNAs coordinately regulate large suites of target 
genes by mRNA degradation and/or translational inhibition. The mRNA target 
specificities of miRNAs in animals are primarily encoded within a 7 nt “seed region” 
mapping to positions 2–8 at the molecule's 5′ end. We here combine computational 
analyses with experimental studies to explore the functional significance of sequence 
variation within the seed region of human miRNAs. The results indicate that a 
substitution of even a single nucleotide within the seed region changes the spectrum of 
mRNA targets by >50%. The high functional cost of even single nucleotide changes 
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within seed regions is consistent with their high sequence conservation among miRNA 
families both within and between species and suggests processes that may underlie the 
evolution of miRNA regulatory control. 
Introduction 
 MiRNAs are small nucleotide RNA molecules that play important regulatory 
roles in cell function (Nazarov, Reinsbach et al. 2013), embryonic development (Alvarez-
Garcia and Miska 2005) and the onset and progression of a variety of diseases (Ha 2011), 
including cancer (Nana-Sinkam and Croce 2010). Like siRNAs and other small 
regulatory RNAs, miRNAs regulate their target genes by mRNA degradation and/or 
translational inhibition (Bartel 2004). However, unlike siRNAs that target one or a few 
genes, individual miRNAs have evolved the ability to coordinately regulate large suites 
of target genes, many of which may encode coordinated cellular functions (Bartel 2004, 
Shahab, Matyunina et al. 2011). The mRNA target specificities of miRNAs in animals 
are primarily encoded within a 7 nt “seed region” mapping to positions 2–8 at the 
molecule's 5′ end (Bartel 2009, Wang 2014).The importance of this 7 nt sequence to 
miRNA function is evidenced by the fact that the seed region sequence of many miRNA 
families is highly conserved both within and between species (Wheeler, Heimberg et al. 
2009). Mature single-stranded miRNAs bound to the RNA-induced silencing complex 
(RISC) recognize their regulatory targets by Watson-Crick base pairing to compatible 
sequences (usually in 3′ un-translated regions or 3′ UTRs) in target mRNAs. 
 It is estimated that there are >1000 sequentially distinct miRNAs in the human 
genome, each being present in a few to hundreds of copies (Kozomara and Griffiths-
Jones 2014). We focused on 249 human miRNAs previously shown to be sequentially 
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conserved across mammalian species (Lewis, Shih et al. 2003). In this study, we combine 
computational analyses with experimental studies to explore the functional significance 
of sequence variation within the seed region of human miRNAs. Our computational 
analyses predict that as few as one nucleotide change within this 7-nt seed region will 
alter the spectrum of targeted mRNAs by >60–70%. Further nucleotide substitutions are 
predicted to have little to no additional effect. Ectopic over expression of synthetic 
miRNAs with variable seed regions (miR-429, miR-141 and miR-205) but with identical 
(miR-429) non-seed regions were conducted to experimentally evaluate the consequence 
of differences in seed region on patterns of gene expression. The experimental results 
again indicate that as few as one nucleotide change within seed regions results in >50% 
alteration in the spectrum of mRNAs directly or indirectly regulated by the over 
expressed miRNA. Further nucleotide differences (5 nucleotide differences) within the 
seed region were found to have no additional effect. The high functional cost of even a 
single nucleotide change within the seed region of human miRNAs is consistent with the 
rigidly conserved seed sequence identity among miRNA families both within and 
between species (Wheeler, Heimberg et al. 2009) and suggests possible mechanisms 
underlying the evolution of miRNA regulatory control. 
Results and Discussion 
 The functional consequence or “cost” of seed region nucleotide changes involves 
the loss of regulatory control over previously targeted mRNAs and/or the acquisition of 
novel regulatory control over previously untargeted mRNAs. To systematically explore 
this phenomenon computationally, we first determined the number of nucleotide changes 
needed to transform one seed region into another (Hamming distance) for each of the 249 
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miRNAs analyzed in this study. We then calculated the percent overlap (cosine 
similarity) of predicted targets for all pairs of miRNAs having identical seeds. For 
example, the percent target gene overlap for miR-25 and miR-32 (both having the seed 
sequence: 5′AUUGCAC) predicted by miRanda-mirSVR is 81% (Fig. 3.1a). The 19% 
(100%–81%) divergence in non-overlapping targets is attributable to sequence variation 
mapping to the non-seed regions (see Figure A.1 for an additional example). The median 
percent overlap between all pairs of conserved miRNAs with identical seeds is 88% 
(Figure 3.1c; Table A.1; n = 144), with an average of 12% divergence in non-overlapping 




Figure 3.1.  A single nucleotide difference in seed region of miRNAs is associated 
with a major change in regulated target genes. a) miR-25 and miR-32, two miRNAs 
with identical seed regions (upper-case letters), have 81% overlap in their predicted target 
genes; b) miR-25 and miR-183, two miRNAs with a single nucleotide difference within 
their respective seed regions have only 18% overlap in their predicted target genes; c) 
The overlap of predicted targets for all 249 pairs of conserved miRNAs grouped by the 
number of mismatches in their respective seed regions. The computed percentage 
overlaps (cosine similarity) are presented as box and whisker plots [the bottom and top of 
each box represent the first and third quartiles of variation while the band inside the box 
represents the median (second quartile) value; the “whiskers” represent variability outside 





 We next independently computed the average percent overlap of predicted mRNA 
targets for pairs of miRNAs having seeds that differ by 1 to 7 nucleotides. The results 
(Figures 3.1b, 3.1c, A.1b; Table A.2) indicate that even a single nucleotide mismatch in 
the seed regions of two miRNAs is computationally predicted to reduce the percent 
overlap (and increase the percent of non-overlap) among their respective targeted 
mRNAs by >70%. The generality of these computational predictions was corroborated 
independently by conducting the same analyses using two additional target prediction 
algorithms, TargetScan and PicTar (Figures A.2a, A.2b). Thus, the computational studies 
consistently predict that as few as one nucleotide substitution within the seed region of 
miRNAs will be associated with significant functional cost and that further changes will 
have little or no additional cost. 
 While informative in their own right, functional predictions based on target 
prediction algorithms alone are often inaccurate in vivo because they ignore the myriad 
of indirect regulatory effects induced by miRNAs (Shahab, Matyunina et al. 2011, Lu and 
Clark 2012, Hill, Matyunina et al. 2014). In an effort to experimentally explore the 
functional cost of nucleotide variation within miRNA seed regions, we selected for 
analysis members of the miR-200 family of human miRNAs that differ by a single 
nucleotide in the seed region (miR-429 vs. miR-141 differ by 1 nucleotide at position 4) 
or differ by multiple nucleotides (miR-429 and miR-205 differ by 5 nucleotides at 
positions 2,3,5,7 and 8) within their respective seed regions (Figure 3.2). In order to 
avoid confounding effects attributable to variation within non-seed regions and to focus 
on the significance of seed region variation, synthetic derivatives of these naturally 
occurring miRNAs were constructed to have identical miR-429 non-seed regions (Figure 
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3.2). In addition, to explore the possible significance of variability in the position of 
single nucleotide differences within seed regions, we constructed an additional miR-429 
variant with a single nucleotide substitution at seed region position 2 (M12, Figure 3.2). 
Each of these miRNAs were independently transfected into the well-characterized HEY 
ovarian cancer cell line (Buick, Pullano et al. 1985) and after 48 hrs RNA was extracted 
and subjected to gene expression analysis (Affymetrix, U133) as previously described 
(Shahab, Matyunina et al. 2012, Jabbari, Reavis et al. 2014) (Tables A.3-A.6 for detailed 
results). 
 
Figure 3.2.  Sequence alignments of miR-429, miR-200b, miR-141, miR-205, M12, 
M14 and M5. Seed and non-seed regions are colored in red and blue, respectively. 
Differences in seed and non-seed regions of miRNAs relative to miR-429 are underlined. 
M12, 14 and M5 all have identical non-seed regions with miR-429. M12 differs in seed 
region sequence from miR-429 by one nt at position 2. The seed region sequence of M14 
is identical to that of miR-141 and differs from the seed of miR-429 by one nucleotide at 
position 4. M5 differs in seed region sequence from miR-429 by 5 nucleotides.  
  
 
 As mentioned above, the functional cost associated with nucleotide changes 
within seed regions is reflective of the loss of regulatory control over previously targeted 
mRNAs and/or the acquisition of novel regulatory control over previously untargeted 





M12= M12 seed (see legend) + miR-429 non-seed 
M14= miR-141 seed + miR-429 non-seed 
M5= miR-205 seed + miR-429 non-seed 
 
 31 
differentially expressed genes in cells transfected by miRNAs with seeds differing by 0 
(miR-429 vs miR-429), 1 (miR-429 vs M12 and miR-429 vs M14) or 5 (miR-429 vs M5) 
nucleotides. Presented in Fig. 3.3c is the observed percent overlap of all significantly 
differentially expressed genes among 3 replicate transfections with miR-429. The high 
similarity in percent overlap among these replicate miR-429 transfections is indicative of 
the low experimental error associated with the technique. Figs. 3.3a and 3.3b present the 
observed percent overlap in significantly differentiated genes in cells transfected with 
miR-429 vs cells transfected by miRNAs differing from miR-429 by a single nucleotide 
within their respective seed regions. The differences are highly significant (χ2 = 1511; 
p<0.0001) and consistent with the prediction that a substantial functional cost is 
associated with even a single nucleotide change within miRNA seed regions. Differences 
in overlap between the miR-429 vs M12 and miR-429 vs M14 comparisons were not 
found to differ significantly (χ2 = 1.95; p<0.16) indicating that, in this experimental 





Figure 3.3.  Overlap among differentially expressed genes in HEY cells after ectopic 
expression of miRNAs with different seed region sequences. An overlap of 85% in 
differentially expressed genes was observed among 3 replicate experiments in which 
miR-429 was ectopically expressed in HEY cells (c). A single nucleotide change in the 
seed region of miR-429 (M12, M14) resulted is a significant reduction (56% vs 85%) in 
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the overlap among differentially expressed genes (a, b). Differences in the position of this 
single nucleotide difference (M12, position 2 vs M14, position 4) did not have a 
significant effect on degree of overlap (a vs.b). Five nucleotide differences in the seed 
region of miR-429 (M5) also resulted in a significant reduction in overlap (56% vs. 85%) 
among differentially expressed genes (d vs. c) but not significantly different from 




 Changes in the percent overlap of significantly differentially expressed genes 
between cells transfected by miR-429 vs those transfected by the miRNA differing at 5 
nucleotide positions within the seed region (Figure 3.3d) were also highly significant (χ2 
= 1535; p<0.0001) but not significantly different from the changes induced by miRNAs 
with only a single nucleotide difference from miR-429 (χ2 = 0.1; p<0.75). 
 Collectively, the above results indicate that even a single nucleotide substitution 
within the seed regions of miRNAs is associated with substantial functional cost and 
suggests an evolutionary model whereby strong stabilizing selection is maintaining rigid 
conservation of miRNA seed sequences both within and between species. Individual 
target genes, on the other hand, may acquire and/or lose miRNA regulatory control(s) 
through even single nucleotide substitutions in miRNA target sequences complimentary 
to miRNA seeds (typically within 3′ UTRs) (Figure 3.4). Any functional consequence of 
such mutations would be incurred on the individual gene level rather than on the multi-
gene level associated with miRNA seed region mutations. This implies that although seed 
regions may be highly conserved both within and between species due to strong 
stabilizing selection, the spectrum of genes regulated by these sequentially conserved 
miRNAs may be expected, on average, to vary significantly, especially between more 
distantly related species where there has been ample time/opportunity for individual 
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genes to acquire variation in their target sequence(s) and to re-associate themselves with 




Figure 3.4.  The high functional cost of even single nucleotide changes in miRNA 
seed regions implies a mechanism of miRNA regulatory evolution. If a miRNA (blue 
square) changes a single nt within its seed region (yellow square), a significant fraction of 
its target genes (blue and yellow ovals) will change resulting in high functional cost. As a 
result, strong stabilizing selection is expected to maintain miRNA seed region sequence 
identity among miRNA families within and between species. In contrast, individual genes 
may change miRNA regulatory control(s) (blue to green squares) by as little as a single 
nucleotide change in their target sequences (blue to gene ovals) with relatively low 
functional cost. Thus, evolutionary changes in miRNA regulatory control are likely to be 






 As an initial test of this prediction, we selected two miRNAs (miR-429 and miR-
200b) that have identical seed regions in both humans and mice (Figure 3.5a). We 
employed the miRanda-mirSVR algorithm to predict the respective orthologous mRNA 
targets of these two miRNAs (human: hsa-miR-429, hsa-miR-200b; mouse: mmu-miR-
429, mmu-miR-200b) in both species. As shown in Figure 3.5b, the percent overlap 
between the predicted gene targets of these two miRNAs (intra-specific) is >90% (mouse: 
93.3%; humans: 91.8%) in both species. However, despite the fact that the human and 
mouse miRNAs share sequentially identical seed regions, they display <40% overlap 
among their respective target genes/mRNAs in the non-native species (inter-specific) 
(Figure 3.5b). To determine if these differences are representative of other sequentially 
conserved miRNAs, we computed the percent overlap of genes targeted by the 249 
miRNAs sequentially conserved in mouse and humans. The results confirm that the 
average overlap between targeted genes in mouse and humans is <30% (Figure 3.5c). 
This dichotomy is well below the false positive values expected given the high stringency 
cut-off values used in our predictions (mirSVR score <−0.2) (Betel, Koppal et al. 2010). 
These results are consistent with the hypothesis that while miRNA seed regions may be 
selectively conserved across species, target genes maintain relative flexibility to acquire 
and/or lose miRNA regulatory controls by even single nucleotide changes within their 





Figure 3.5.  Mouse and human miRNAs share sequentially identical seed regions but 
regulate highly divergent groups of target genes. a) Sequence alignment between 
human (has-miR-429/200b) and mouse (mmu-miR-429/200b) miR-429 and miR-200b 
miRNAs. Despite the substantial evolutionary distances between these two species, the 
respective seed regions are sequentially identical indicative of strong stabilizing 
selection. b) Venn diagrams showing the % overlap in predicted miR-429 and miR-200b 
target genes between human and mouse orthologs. c) The average percent overlap of 
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genes predicted to be targeted by all 249 sequentially conserved mouse and human 
miRNAs is <30%. The results are consistent with a model of miRNA regulatory 
evolution whereby miRNA seed region sequences are selectively conserved while target 
genes may rapidly re-position themselves under novel miRNA regulatory control(s). 
 
 
 Collectively, our findings support an evolutionary model whereby miRNAs 
initially evolve to regulate large suites of target genes. Thereafter, the sequential integrity 
of miRNA seed regions is maintained by strong stabilizing selection due to the high 
functional cost of even a single nucleotide mutation within miRNAs. In contrast, 
nucleotide mutations in the target sequences of individual genes, being, on average, of 
substantially lower functional cost, allow for a relatively rapid repositioning of miRNA-
target gene associations. Indeed, a variety of scenarios might arise to buffer the possible 
negative effects of target sequence mutations in regulated genes. For example, 
duplication of specific target sequences within regulated genes could serve to mask the 
impact of the sudden loss of existing miRNA regulatory controls while still permitting 
genes to explore the potential adaptive benefits of acquiring new miRNA regulatory 
controls. 
Materials and Methods 
Computational predictions of miRNA target and overlap 
 To determine the mRNA targets of the 249 conserved miRNAs, we utilized three 
online target prediction programs, miRanda-mirSVR (Betel, Koppal et al. 2010), 
TargetScan (Friedman, Farh et al. 2009) and PicTar (Krek, Grun et al. 2005). The 
miRanda predictions are driven by mirSVR, an application that uses machine learning to 
evaluate and score the importance of various features from miRNAs and their putative 
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target sites. Predicted miRNA targets were filtered for targets with a mirSVR score less 
than −0.2 to minimize false positives. Corroborative predictions were carried out using 
TargetScan and PicTar. 
 We determined the distance between two sequences by calculating the Hamming 
distance (Hamming 1950). That distance is calculated by counting the number of 
nucleotide changes needed to transform one seed sequence into another. Overlap between 
the predicted miRNA targets was determined using cosine similarity (Tan 2005), 
calculated by dividing the total number of overlapping genes by the square root of the 
product of the number of genes targeted by each miRNA. Taking the square root of the 
number of predicted targets reduces the influence of miRNAs with abnormally large 
numbers of targets and simultaneously normalizes the result, generating a score between 
0 and 1. The significance of the difference in overlap of differentially expressed genes 
between two pairs of miRNAs was calculated using the chi-square test of association; the 
overlap and cost (non-overlap) for each pair were compared. 
Cell culture and transfections 
 HEY (Buick, Pullano et al. 1985) ovarian cancer cells, provided by Gordon B. 
Mills (MD Anderson Cancer Center, Houston, TX), were cultured in RPMI-1640 
(Mediatech, Manassas, VA) with 10% Fetal Bovine Serum (FBS, Atlanta Biologicals, 
GA) and 1% antibiotic-antimycotic solution (Mediatech-Cellgro, Manassas, VA), and 
incubated at 37°C and 5% CO2. The transfection protocol was as described previously 
(Jabbari, Reavis et al. 2014). Briefly, triplicate wells of exponentially growing cells were 
transfected with miR-429, and the custom designed miRNAs M12, M14 and M5 
purchased as Pre-miR miRNA Precursors (Ambion, Austin, TX). Transfections were 
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performed using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA) 
according to the manufacturer's instructions. Ambion Pre-miR miRNA Precursor 
Negative Control was used as a negative control. 
RNA isolation and whole genome microarray 
 RNA was extracted from transfected cells using the RNeasy Mini RNA isolation 
kit (QIAGEN, Valencia, CA). Microarray experiments were performed as previously 
described (Shahab, Matyunina et al. 2012). Briefly, RNA samples with high integrity 
were converted to cDNA and amplified with Applause 3′-Amp System (NuGen, San 
Carlos, CA). The cDNA was fragmented and Biotin labeled using the Encode Biotin 
Module (NuGen). Labeled cDNA was then hybridized to Affymetrix HG-U133 Plus 2.0 
arrays and analyzed with GeneChip Scanner 3000 (Affymetrix, Santa Clara, CA). 
Microarray data analysis 
 To determine differentially expressed genes in triplicates of experimental miRNA 
and negative control treated cells, the following procedure was followed. Quality control 
was first assessed using all raw CEL files as implemented in Array Analysis (Eijssen, 
Jaillard et al. 2013). GC Robust Multi-array Average (GCRMA) normalization was 
performed using all CEL files that passed quality control (n = 3 per experimental group 
after quality assessment). For GCRMA normalization, each experimental miRNA group 
was compared independently to the negative control group. Next, probe set filtering was 
performed as follows: present/absent calls were first generated by Microarray Suite 5.0 
(MAS5.0) using the Affymetrix Expression Console v1.1. Based on present/absent calls, 
probe sets with less than 50% present calls across all experimental miRNA and negative 
control samples were removed. In addition, probes and probe sets lacking a gene symbol 
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annotation were ignored. Based on GCRMA expression signals, calculation of signal-to-
noise ratio (SNR = mean/standard deviation) was used to select and keep only the probe 
sets with the highest SNR for differential expression profiling. GCRMA expression 
signals for those probe sets were submitted to SAM (Significance Analysis of 
Microarrays) (Tusher, Tibshirani et al. 2001). Each SAM input file contained triplicates 
of experimental miRNA and negative control GCRMA expression columns. 
Differentially expressed genes in each experimental miRNA group were determined 
compared to the negative control (as a baseline) using the false discovery rate (FDR) 
<2%. SAM output files included significantly differentially expressed genes (upregulated 
and down-regulated genes in separate lists). All raw CEL files, MAS5.0 (CHP files) and 
GCRMA processed files are deposited in the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov) SuperSeries number GSE56973. 
Orthologous genes 
 Orthologous genes in human and mouse were identified using the BioMart data-
mining tool (Kasprzyk 2011). Briefly, all Homo sapiens genes were selected on BioMart 
and filtered to remove the genes with no mouse orthologs. The output file included the 
mouse orthologs for all the resulting genes. These genes were then used for our 










EVIDENCE FOR FUNCTIONALLY SIGNIFICANT INTERACTIONS 
BETWEEN SEED REGION AND NON-SEED REGION AMONG MEMBERS OF 
THE MIR-200 FAMILY OF MICRORNAS 
 
Preliminary comments 
 Contents of this chapter will soon be submitted for publication. The author 
contribution to experiments and data analyses are as follows: I designed and conducted 
all the wet lab experiments including cell culturing, transfection, drug sensitivity assays 
and PCR gene expression profiling. I collaborated with Dr. Lilya Matyunina in carrying 
out the microarray experiments.  
Abstract 
 MicroRNAs are small (22bp) non-coding RNAs that regulate large suites of target 
genes by mRNA degradation and/or translational inhibition. Over-expression of miR-
200b in mesenchymal-like ovarian cancer cells significantly increases sensitivity to the 
chemotherapeutic drug cisplatin. This functionally significant change has been previously 
associated with sequence variation mapping to the non-seed region on mir-200b. We 
confirm these earlier findings and report that the miR-200b induced increase in drug 
sensitivity is correlated with significant changes in patterns of gene expression including 
the down-regulation of 6 genes previously associated with cisplatin resistance in cancer 
cells. We further report that substitution of a single nucleotide within the mir-200b seed 




Collectively, our results provide evidence for seed region/non-seed interactions in 
the regulation of miRNA-induced cisplatin resistance in ovarian cancer cells. 
Introduction 
MicroRNAs (miRNAs) are small (22bp) non-encoding RNAs that play important 
roles in cell function (Nazarov, Reinsbach et al. 2013) by coordinately regulating large 
suites of target genes (Bartel 2004, Shahab, Matyunina et al. 2011), Regulation is brought 
about by miRNA binding to complementary sequences within the mRNAs of target genes 
that blocks translation and/or leads to mRNA degradation (Bartel 2004). Numerous 
studies have demonstrated that miRNA binding to target mRNAs is primarily determined 
by a sequentially conserved region within the miRNA (“seed region”) mapping to 
positions 2-8 within the the 5' end of the miRNAs (Bartel 2009, Wang 2014). Despite the 
importance of seed region in miRNA function, more recent studies indicate that sequence 
pairing between seed regions and target mRNAs is not always sufficient for miRNA 
function (Grimson, Farh et al. 2007). For example, productive 3′ pairing on miRNA 
nucleotides 13–16 ( “3’-supplementary sites”) and pairing centered on miRNA 
nucleotides 13–17 ( “3′-compensatory sites”), has been shown to supplement seed region 
pairing, and/or compensate for a single nucleotide mismatches  between miRNAs and 
their targeted mRNAs mapping to the seed region(Bartel 2009).  
We have recently provided preliminary evidence that the non-seed region 
(position 9-21) of miR-200b plays a significant role in conferring cisplatin sensitivity 
when ectopically over-expressed in mesenchymal-like, HEY ovarian cancer cells 
(Jabbari, Reavis et al. 2014). To explore this hypothesis in more detail, we combined the 
miR-200b non-seed region with a seed region differing from miR-200b by only a single 
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nucleotide substitution. Combining the miR-200b non-seed region with a heterologous 
seed region resulted in a the loss of the ability of the chimeric miRNA to confer cisplatin 
sensitivity when over-expressed in HEY cells and a correlated elevation in genes 
previously associated with increased cisplatin resistance in a variety of cancer cells. The 
results indicate that the functional significance of the miR-200b non-seed region is 
dependent upon the seed region sequence with which it is paired. 
Results 
The naturally occurring miR-429 and miR-200b microRNAs have identical seed 
regions but highly divergent non-seed regions (Figure 4.1a). We have recently reported 
that despite the ability of miR-429 and miR-200b miRNAs to induce Mesenchymal 
Epithelial Transition (MET) in HEY cells, the two miRNAs confer a significantly 
different response to cisplatin in these cells. Specifically, miR-200b transfected cells are 
significantly more sensitive than miR-429 transfected cells (Figure 4.1b) (Jabbari, Reavis 
et al. 2014). Given that the two miRNAs have identical seed and different non-seed 
regions, the observed differences in the cisplatin response profiles can be attributed to 










Figure 4.1. Effect of over expression M4b in HEY cells on cisplatin sensitivity. (a) 
Sequence alignment of mature miR-200b, miR-429 and M4b miRNAs. Nucleotides in 
red correspond to differences from miR-200b sequence. (b) IC50 values are presented as 
mean ± SEM of at least 3 independent experiments with 3 replicated wells per drug 
concentration. Statistical analysis was performed using t-test. Asterisks represent 
significant differences from the paired miRNA, * P ≤0.05, ** P ≤0.005. 
 
To test the hypothesis that the miR-200b non-seed region itself is responsible for 
conferring cisplatin resistance when over-expressed in HEY cells, we produced a 
synthetic miRNA (M4b) identical in sequence to miR-200b except for a single nucleotide 
substitution within the seed region (Figure 4.1a).  A series of miRNA transfection 
experiments were carried out with M4b, miR200b and miR-429- a naturally occurring 








within its non-seed region. MiR-200b was significantly more sensitive to cisplatin than 
cells over-expressing miR-429. As previously reported (Jabbari, Reavis et al. 2014), this 
finding associates the observed increase in sensitivity to cisplatin with the non-seed 
region of miR-200b. However, the cisplatin sensitivity of cells over-expression M4b is 
indistinguishable from that observed in cells over-expressing miR-429 (Figure 4.1). Thus, 
the increased sensitivity to cisplatin of cells over-expressing miR-200b and associated 
with the non-seed region is lost when as little as a single nucleotide substitution is made 
in the miR-200 seed region sequence. Collectively, our results indicate that the seed and 
non-seed regions of miR-200b functionally interact with respect to conferring cisplatin 
sensitivity when over-expressed in HEY cells. 
To explore the potential molecular factors leading to the observed variation in 
cisplatin response, we conducted genome-wide gene expression analysis (Affymetrix hg-
u133 plus 2.0 arrays) of hey cells transfected with miR-200b or miR-429. From among 
the significantly differentially expressed 5229 and 9224 genes in miR-429 and miR-200b 
transfections respectively, 4368 genes were in common accounting for 62.9% overlap in 
differentially expressed genes induced by over-expression of these miRNAs. Replicate 
experiments carried out with miR-429 and miR-200b resulted in overlaps of 85.4% and 
88.4% respectively. This variability can be attributed to experimental error. The 
significantly lower degree of overlap between miR-429 and miR-200b can be attributed 





Figure 4.2. Overlap among differentially expressed genes in HEY cells transfected 
with miRNAs with different non seed regions. An average overlap of 88.4% and 85.4% 
in differentially expressed genes was observed among any two miR-429 and miR-200b 
microarray replicates (out of total n= 3) paired with negative control (n=3). Nucleotide 
differences in the non-seed region of miR-200b (miR-429) resulted is a significant 
reduction (62.9%) in the overlap among differentially expressed genes. 
 
From among the list of all significantly differentially expressed genes in the 
microarray experiments, we selected a panel of six genes (Table 4.1) that have been 
previously associated with cisplatin resistance in a variety of cancers. The microarray 
analysis indicated that all six of these genes were significantly down-regulated in the 
miR-200b transfected cells relative to the miR-429 transfected cells consistent with the 
observed increase in cisplatin sensitivity associated with the miR-200b non-seed region. 
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The down-regulation of these genes in HEY cells over-expressing miR-200b relative to 
cells transfected by miR-429 were confirmed by qRT-PCR (Figure 4.3). Interestingly, the 
expression pattern of these 6 genes in cells over-expressing M4b was indistinguishable 
from what was observed in cells over-expressing miR-429 and consistently different from 
what was observed in cells over-expressing miR-200b. Thus, both the down-regulated 
pattern of expression of these genes and the observed increase in cisplatin sensitivity 
associated with the miR-200b non-seed region were lost when a single nucleotide change 
was made in miR-200b’s seed region.  
 
Table 4.1. Representative genes associated with cisplatin resistance that are down 
regulated in miR-200b transfection and not changed in miR-429 transfection. 




- TYMS catalyzes the reductive methylation of dUMP by CH2H4folate 
providing the sole de novo source of thymidylate which is essential for 






- TYMS is important determinant of drug resistance to cisplatin in Human 
Non–Small-Cell Lung Cancer cells.  




- An epithelial isoform of a family of soluble cytoplasmic proteins. 
- Majorly involved in membrane permeability, exocytosis and regulation of 
ion channels. 
(Hill, Kaetzel 
et al. 2003), 
(Sohma, 
Creutz et al. 
2001), 
(Kaetzel, 
Chan et al. 
1994) 
- ANXA4 is overexpressed in ovarian clear cell carcinoma. 
- Knockdown of its expression in human ovarian clear cell carcinoma cell 









- A member of the cullin family of proteins that is in general involved in cell 
cycle regulation and maintenance of genomic stability. 
(Sharma and 
Nag 2014) 
- Knockdown of its expression leads to inhibition of cancer cell growth and 
apoptosis. 
- Knock down of its expression in lung cancer cells increased their sensitivity 
(Liu, Lee et 
al. 2009), 
(Yang, Hung 
et al. 2014) 
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factors of the O 
class (FOXO1) 
- Critical regulator of cellular growth and proliferation and are therefore 
considered to be potential targets for therapeutic strategies against cancer. 
(Maiese, 
Chong et al. 
2008) 
- It has been indicated to inhibit cisplatin-induced apoptosis in gastric cancer 
cells. 







- It encodes a GTP binding protein belonging to the Rho family of small 
GTPases, which regulate cellular functions during embryonic development 
and tumor invasion. 
(Fritz, Just et 
al. 1999) 
- Its down regulation is associated with increased cell sensitivity to cisplatin 
and cisplatin-induced apoptosis in human cervical epithelial 
adenocarcinoma cell line 
(Xu, Yu et al. 
2013) 
Gelsolin (GSN) - A cytoskeleton-associated protein and most cancer cells have significantly 











et al. 1996), 
(Zhang, Zhou 
et al. 1997) 
- Its overexpression inhibits cisplatin induced apoptosis in chemosensitive 
cells and its down regulation sensitizes cisplatin-resistant cancers. 
(Wang, 



































Figure 4.3. Expression levels of representative cisplatin resistance genes in miRNA 
transfected cells are predictive of the cells’ response to cisplatin. Consistent with the 
higher cisplatin sensitivity in miR-200b transfected cells as compared to miR-429 and 
M4b transfections, expression levels of representative  genes associated with cisplatin are 
decreased in miR-200b transfection meanwhile not changed or up-regulated in miR-429 
and M4b transfections.  (a) Heatmaps represent z-score normalized log expression values 
for the six representative genes in miR-200b, miR-429 tranfections normalized to the nc-
miR transfection (Affymetrix HG-U133 Plus 2.0 arrays). (b) Relative expression of the 
six representative genes in miR-200b, miR-429 and M4b transfected cells using qRT-
PCR. Values are normalized to nc-miR transfected cell and represent mean ± SEM of at 
least three biological replicates each performed in three technical replicates. Asterisks 




MicroRNAs (miRNAs) are endogenous ~22-nucleotide RNAs that play important 
gene-regulatory roles in animals and plants by pairing to the mRNAs of protein-coding 
genes to direct their posttranscriptional repression (Bartel 2009). Pairing to the 5’ portion 
of the miRNA, known as seed region and comprised of nucleotides 2–8, appears to be 
most important for target recognition by vertebrate miRNAs (Lewis, Shih et al. 2003). 
Most mammalian protein-coding genes are under selection to maintain pairing to the seed 
of one or more miRNAs (Lewis, Burge et al. , Farh, Grimson et al. 2005) illustrating the 
broad scope of seed-type regulation.  
Despite the demonstrated importance of the seed regions in miRNA targeting, 
several recent studies indicate that sequence pairing of seed regions with target mRNA 
sequences is not always sufficient for repression(Grimson, Farh et al. 2007). For 
example, a recent study by Wang et al., demonstrated that binding stability of the paired 
nucleotides was a major determinant of miRNA targeting patterns, whether involving 
seed or non-seed sequences (Wang 2014). Pairing to the 3′ region of the miRNA can 
supplement seed pairing to enhance target recognition, or it can even compensate for a 
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single nucleotide bulge or mismatch in the seed region (Bartel 2009). These sites have 
been designated “3’-supplementary sites” and “3′-compensatory sites”, respectively. In 
supplementary sites, productive 3′ pairing optimally centers on miRNA nucleotides 13–
16 and in “3′-compensatory sites”, the pairing centered on miRNA nucleotides 13–17 
extends to at least nine contiguous Watson–Crick pairs (Bartel 2009).  
Results reported in this study confirm our earlier evidence for the functional 
significance of the non-seed region of miR-200b (nucleotides 9-21) in imparting 
increased cisplatin sensitivity in cells ectopically over-expressing the miRNA. In 
addition, our results demonstrate that this induced increase in drug sensitivity is 
correlated with a significant change in global patterns of gene expression including the 
reduction in levels of expression of six genes previously associated with cisplatin 
sensitivity in a variety of cancer cells (Table 4.1). Most interesting, was our finding that a 
single nucleotide change in the seed region of miR-200b is sufficient to lose the functions 
previously associated with the miRNAs non-seed region. Collectively our results indicate 
that, at least in some contexts, the functional significance of the non-seed region is 
dependent upon the seed region with which it is paired. 
Material and Methods 
Cell culture and miRNA transfection 
HEY ovarian cancer cell lines were cultured in RPMI 1640 (Mediatech, 
Manassas, VA) supplemented with 10% FBS (Fetal Bovine Serum; Atlanta Biologicals, 
Lawrenceville, GA) and 1% antibiotic-antimycotic solution (Mediatech-Cellgro, 
Manassas, VA). MiRNA transfections were performed as previously described , Briefly, 
triplicate 24-well plate wells of cells at exponential phase of growth were transfected 
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with 30 nM miRNAs purchased as Pre-miR miRNA Precursors (Ambion, Austin, TX) 
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and according to the 
manufacturer’s instructions. RNA isolation was performed 48 hours post transfection. 
Ambion Pre-miR miRNA Precursor Negative Control was used as a negative control (nc-
miR). 
Quantitative reverse transcription real-time PCR (qRT-PCR)  
RNeasy mini kit (Qiagen, Valencia, CA) was used to extract total RNA. RNA 
concentrations were measured using a NanoDrop 1000 Spectrophotometer V3.2 
(NanoDrop, Wilmington, DE). RNA samples were converted into first-strand cDNA with 
the Superscript III First-strand Synthesis System (Invitrogen, Carlsbad, CA). iQ SYBR 
Green Supermix (Bio-Rad, Hercules, CA) was used to perform Real-time PCR analyses 
on the CFX96 real-time PCR system (Bio-Rad, Hercules, CA). The primer sequences 
employed are provided in Table C.1. The relative amount of the target RNA was 
calculated using the threshold cycle and ΔΔCt method. GAPDH was used as a reference 
gene to normalize expression values. 
RNA isolation and whole genome microarray 
RNA was extracted from cells using the RNeasy Mini RNA isolation kit 
(QIAGEN, Valencia, CA). RNA samples with high integrity were converted to cDNA 
and amplified with Applause 3’-Amp System (NuGen, San Carlos, CA). The cDNA was 
fragmented and Biotin labeled using the Encode Biotin Module (NuGen). Labeled cDNA 
was hybridized to Affymetrix HG-U133 Plus 2.0 arrays and analyzed with GeneChip 
Scanner 3000 (Affymetrix, Santa Clara, CA).  
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Microarray data analysis 
To determine differentially expressed genes in experimental miRNA and negative 
control treated cells, quality control was first assessed using raw CEL files as 
implemented in Array Analysis (Eijssen, Jaillard et al. 2013). GCRMA normalization 
was performed using CEL files that passed quality control. For GCRMA normalization, 
experimental miRNA samples (n=3 for each of miR-429 and miR-200b transfections) 
were independently compared to the negative control samples (n=3). Microarray Suite 
5.0 (MAS5.0) from the Affymetrix Expression Console v1.1 was used to generate 
present/absent calls. Probe sets with less than 50% present calls across all miRNA and 
negative control samples and probe sets lacking a gene symbol annotation were removed. 
GCRMA expression signals for probe sets with the highest mean/standard deviation ratio 
were submitted to SAM (Significance Analysis of Microarrays) (Tusher, Tibshirani et al. 
2001) and differentially expressed genes in each experimental miRNA group were 
determined relative to the negative control (FDR< 2%). CEL files, CHP files and 
GCRMA processed files are listed in the Gene Expression Omnibus under GSE56967 
and GSE56969. 
Cisplatin sensitivity 
Quantitative assessment of cell response to cisplatin was performed as previously 
described (Jabbari, Reavis et al. 2014). Briefly, exponentially growing cells in 96-well 
plates were treated with a range of cisplatin concentrations. In order to measure the 
fluorescence (λex = 560 nm, λem = 590 nm), TOX-8 reagent (Sigma-Aldrich, St Louis, 
MO) was added to the wells after 72 hours. Outliers were removed using Grubbs’ test. 
Growth (% of control) was determined using the ratio of the background-subtracted 
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fluorescence intensities of drug treated to untreated cultures was calculated in 
percentages. To calculate IC50 for each group, non-linear regression of log-transformed 
data with a normalized response-variable slope model was determined by GraphPad 
Prism v.6 (GraphPad Software Inc., La Jolla, CA). IC50 values are determined using at 
least three independent transfection experiments. In each independent experiment, 





















MicroRNAs have recently emerged as one of the master regulators of cell 
function by pairing to the mRNAs of protein-coding genes to direct their repression 
(Bartel 2009). The mRNA target specificities of miRNAs in animals are primarily 
encoded within a region mapping to the molecule's 5′ end known as seed region. Most 
mammalian protein-coding genes are under selection to maintain pairing to the seed of 
one or more miRNAs (Lewis, Burge et al. , Farh, Grimson et al. 2005) illustrating the 
broad scope of seed-type regulation. Throughout the chapters 2 and 3, we have 
investigated the functional significance of sequence variation within the seed regions of 
miRNAs. 
Results in chapter 2 are promoted by our earlier finding on the ability of miR-429 
(a miR-200 family member) to induce reversal of EMT (MET) in OC mesenchymal-like 
cells. We systematically explored the significance of sequence variation among members 
of this family in OC mesenchymal-like cells. Our results indicated that even though the 
MET-inducing properties of miR-429 in these cells extends to other members of the miR-
200 family, the underlying molecular changes are variable and attributable to sequence 
variation within the seed region of individual family members.  
In chapter 3, in order to explore the functional significance of seed sequence 
variation of human miRNAs, we initially computed and compared the overlap of all 
conserved human miRNA predicted targets among miRNAs with identical or non-
identical seed regions. The results indicated that substitution of even a single nucleotide 
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within the seed region dramatically changes the spectrum of miRNA targets. Next, we 
experimentally validated this observation by measuring the systematic effects of a set of 
synthetic miRNAs with non-identical seed and identical non-seed regions. The observed 
high functional cost of even a single nucleotide change within miRNA seed regions is 
suggestive of an evolutionary model whereby miRNA sequence is under stabilizing 
selection to maintain regulation of large suits of genes and on the other hand, lower cost 
associated with substitutions within the sequence of the target mRNAs allows for the 
evolution of their regulation by miRNAs.  
Despite the importance of the seed region in miRNA targeting, recent studies 
indicate that pairing of seed regions with target mRNA is not always sufficient for 
repression(Grimson, Farh et al. 2007) and the miRNA’s 3’ end or the non-seed region, 
might also play an important role in miRNA targeting. For example, pairing to the 3′ end 
of the miRNA can supplement seed pairing to enhance target recognition, or it can even 
compensate for a single nucleotide bulge or mismatch in the seed region (Bartel 2009). 
Throughout the chapters 2 and 4, we provide evidence on the functional significance of 
sequence variation within the non-seed regions of miRNAs: 
In chapter 2, consistent with the studies that have shown that OC cells induced to 
undergo EMT display a significantly decreased sensitivity to platinum-based drugs 
(Haslehurst, Koti et al. 2012, Marchini, Fruscio et al. 2013), we determined that miR-200 
family induced MET in OC cells is generally correlated with a significant increase in 
sensitivity to cisplatin. However, significant variation was associated with sequence 
variation mapping to the non-seed region of individual miR-200 family members. In this 
case, miR-200b conferred a much higher sensitivity to cisplatin relative to miR-429 with 
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an identical seed region. In Chapter 4, we demonstrate that this induced increase in drug 
sensitivity relative to miR-429, is correlated with a significant change in global patterns 
of gene expression including the reduction in levels of expression of six genes previously 
associated with cisplatin sensitivity in a variety of cancer cells. More interestingly, both 
the down-regulated pattern of expression of these genes and the observed increase in 
cisplatin sensitivity associated with the miR-200b non-seed region were lost when a 
single nucleotide change was made in miR-200b’s seed region. Therefore, we provide 
evidence that, at least in some contexts, the functional significance of the non-seed region 
is dependent upon the seed region with which it is paired.  
The development of multicellularity is accompanied by significantly increased 
complexity of gene regulation. This complexity is reflected in many levels of regulation 
primarily at the transcription level by transcription factors (TFs) and/or at the post-
transcription level by miRNAs. MiRNA mediated regulation is qualitatively different 
from TF mediated regulation. TFs contain discrete domains for exerting their functions, 
known as DNA-binding domains and protein-protein interaction domains. Because TFs 
have such functional units, which may individually acquire mutations and be lost or 
gained over time, they are modular and, thus, have opportunities to evolve in ways that 
minimize pleiotropy (Cheatle Jarvela and Hinman 2015). However, on the other side, 
miRNAs are small RNAs whose structure and function are not inherently modular. 
MiRNAs exert their direct regulatory function mainly through an almost perfect 
complementary base pairing between their seed region (in animals), or the whole miRNA 
sequence (in plants) and their target genes. In fact, as has been reported in this study, a 
single mutation in the seed region leads to a significant shift in the spectrum of miRNA 
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regulated genes. Therefore, any modulations in the miRNA seed are more likely to 
directly rewire gene expression networks and this may profoundly influence signaling 
pathways and serve as a base to develop malignancy. However, given that many genes in 
a genome are regulated by a synergistic network of miRNAs and TFs (i.e., the cascaded 
form, feed forward or feedback loops)(Li, Li et al. 2013), mutations in miRNA and TFs 
affect each other. Thus, emergence of malignancy could more be the consequence of a 
disrupted close synergistic regulation at transcriptional and post-transcriptional levels that 
is initially triggered by modulations in either TF or miRNA regulated networks. 
In general, our studies support the potential therapeutic significance of groups of 
miRNAs and suggest that exogenous modulations in the expression of miRNAs involved 
in EMT may serve as the basis of important new strategies in the treatment of ovarian and 






SUPPLEMENTARY DATA FOR CHAPTER 3 
 
Table A.1. Target overlap for miRNAs with identical seeds. Predicted (miRanda-
mirSVR) overlap (cosine similarity) in target genes for all pairs of miRNAs with 
identical seed regions. 
 
Please see table on our website: 
http://www.mcdonaldlab.biology.gatech.edu/dissertations/jabbari.htm 
 
Table A.2.Target overlap for miRNAs with non-identical seeds. Predicted (miRanda-
mirSVR) overlap (cosine similarity) in target genes for all pairs of miRNAs with non-
identical seed regions. 
 
Please see table on our website: 
http://www.mcdonaldlab.biology.gatech.edu/dissertations/jabbari.htm 
Table A.3. Fold-change for all (5229) significantly differentially expressed genes 
after ectopic expression of miR-429 in HEY cells.  
 
Please see table on our website: 
http://www.mcdonaldlab.biology.gatech.edu/dissertations/jabbari.htm 
Table A.4. Fold-change for all (10456) significantly differentially expressed genes 
after ectopic expression of M12 in HEY cells.  
 
Please see table on our website: 
http://www.mcdonaldlab.biology.gatech.edu/dissertations/jabbari.htm 
 
Table A.5. Fold-change for all (11277) significantly differentially expressed genes 
after ectopic expression of M14 in HEY cells.  
 
Please see table on our website: 
http://www.mcdonaldlab.biology.gatech.edu/dissertations/jabbari.htm 
 
Table A.6. Fold-change for all (10475) significantly differentially expressed genes 
after ectopic expression of M5 in HEY cells.  
 






Figure A.1. One nucleotide difference or 7 nucleotide differences in the seed regions 
of miRNAs is predicted to be associated with equivalent levels of change in 
regulated target genes. (a) miRNAs with identical seeds, miR-195 and miR-16, are 
predicted to share 91% of their target genes; (b) miRNAs with a single nucleotide change 
in their seed regions, miR-195 and miR-29a, are predicted to share only 21% of their 
target genes; (c) miRNAs with no sequence similarity in their seed regions, miR-195 and 
miR-205, are predicted to share only 18% of their target genes. These results are 
consistent with the hypothesis that as little as a single nucleotide difference within 




Figure A.2. Distribution of percent overlap of miRanda-mirSVR predicted targets 
of miRNAs having 0 through 7 seed mismatches. Insets show distribution according to 
two other popular prediction algorithms: a) TargetScan, and b) PicTar. The results are 
uniformly consistent with the prediction that even a single nucleotide mismatch within 


















SUPPLEMENTARY DATA FOR CHAPTER 4 
 
Table B.1. Primer sequences used for the expression measurement of the six genes 
Target Primer sequence 
TYMS Forward: 5’-CAGATTATTCAGGACAGGGAGTT-3’  
Reverse: 5’-CATCAGAGGAAGATCTCTTGGATT-3’ 
ANXA4 Forward : 5’-GGAGGTACTGTCAAAGCTGC-3’  
Reverse:  5’-GCCACTCAGTTCTGACTTCAG-3’ 
CUL4A Forward: 5’-GGAAAGCACAGTGGTCGAA-3’  
Reverse: 5’-GGGACACCTGGAATTCCTTC-3’ 
FOXO1 Forward: 5’-GCAGATCTACGAGTGGATGGTC-3’  
Reverse: 5’-AAACTGTGATCCAGGGCTGTC-3’ 
Rac1 Forward: 5’-GCGGCACCACTGTCCCAACA-3’  
Reverse: 5’-AGCGCCGAGCACTCCAGGTA-3’ 
GSN Forward : 5’-GGTGCAGAGACTCTTCCAGG-3’  
Reverse:  5’-CTGTTGGAACCACACCACTG-3’ 
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